沃特股份(002886.SZ)年產5000噸液晶高分子(LCP)材料項目建成投產
格隆匯 9 月 6日丨沃特股份(002886.SZ)發佈公告,公司全資子公司江蘇沃特特種材料製造有限公司使用自有資金投資建設的年產5000噸液晶高分子(LCP)材料項目已於近日建成投產並一次性試料合格,相關產品已得到客户認可和使用。公司現已具備年產8000噸液晶高分子(LCP)材料生產能力。
該項目投產將有助於提升公司相關產品產能,滿足下游5G、消費電子、汽車電子、電氣等行業客户不斷增加的訂單需求;優化薄膜級液晶高分子(LCP)材料出貨能力,與原有產線產品形成規模經濟效應,提升產能利用率並降低生產成本;加強公司產品綜合競爭力,增加公司回報股東能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.